Using the retroviral BCR-ABL1 model to induce myeloproliferative-like disease, which serves as a model for CML, researchers found that the conditional deletion of the Klf4 gene prolonged overall survival. This evidence concerns the gene KLF4 and chronic myelogenous leukemia, BCR-ABL1 positive.